Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancer.

Jacob I TaylorAshish M KamatMichael A O'DonnellDrupad AnnapureddyJeffrey M HowardWei Shen TanIan M McElreeFacundo DavaroKendrick YimStephen HarringtonElizabeth DyerAnna J BlackPratik KanaburMathieu RoumiguiéSeth LernerPeter C BlackJay D RamanMark A PrestonGary SteinbergWilliam HuangRoger LiVignesh T PackiamSolomon L WolduYair Lotan

Published in: BJU international (2024)

In a selected cohort of patients, initial BST offers comparable survival outcomes to upfront RC in the intermediate term. Rates of recurrence and progression increase over time especially in patients treated with additional lines of BST.

Keyphrases

muscle invasive bladder cancer
end stage renal disease
chronic kidney disease
newly diagnosed
stem cells
mesenchymal stem cells
patient reported outcomes
robot assisted